These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36464876)
1. Pharmacokinetics and Tissue Distribution of Nasal Spray of a Novel Muscarinic Receptor Blocker, 101BHG-D01, in Dogs and Rats. Wei H; Wu L; Jia Y; Shen J; Li Y; Sun P; Xie Q; Chen X; Xie Y; Wang Y; Zhao Z Curr Drug Metab; 2022; 23(13):1080-1088. PubMed ID: 36464876 [TBL] [Abstract][Full Text] [Related]
2. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study. Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects. Gao H; Cheng M; Liu H; Ding L J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657 [TBL] [Abstract][Full Text] [Related]
4. Effects of 101BHG-D01, a novel M receptor antagonism, on allergic rhinitis in animal models and its mechanism. Shen H; Wei H; Jiang J; Yao H; Jia Y; Shen J; Li Y; Xie Q; Chen X; Xie Y; Dai H Eur J Pharmacol; 2023 Sep; 955():175902. PubMed ID: 37422119 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, Mass Balance, Tissue Distribution and Metabolism of [ Gao H; Yang C; Hu W; Ding J; Diao X; Zheng Y; Shu C; Ding L Curr Drug Metab; 2023; 24(11):770-779. PubMed ID: 38073103 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Gao H; Li J; Chen X; Sun Z; Cui G; Cheng M; Ding L Front Pharmacol; 2022; 13():1064364. PubMed ID: 36588683 [TBL] [Abstract][Full Text] [Related]
7. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis]. Jia MH; Chen XY; Zhang Y; Liao ZS Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264 [No Abstract] [Full Text] [Related]
8. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ratner PH; Hampel FC; Amar NJ; van Bavel JH; Mohar D; Marple BF; Roland PS; Wall GM; Brubaker MJ; Drake M; Turner D; Silver LH Ann Allergy Asthma Immunol; 2005 Nov; 95(5):474-9. PubMed ID: 16312171 [TBL] [Abstract][Full Text] [Related]
9. A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis. Stern MA; Dahl R; Nielsen LP; Pedersen B; Schrewelius C Am J Rhinol; 1997; 11(4):323-30. PubMed ID: 9292184 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902 [TBL] [Abstract][Full Text] [Related]
11. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group. Creticos P; Fireman P; Settipane G; Bernstein D; Casale T; Schwartz H Allergy Asthma Proc; 1998; 19(5):285-94. PubMed ID: 9801742 [TBL] [Abstract][Full Text] [Related]
12. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Spangler DL; Abelson MB; Ober A; Gotnes PJ Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132 [TBL] [Abstract][Full Text] [Related]
13. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups. Berger WE; Fineman SM; Lieberman P; Miles RM Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis. Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis. Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031 [TBL] [Abstract][Full Text] [Related]
17. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Bernstein JA Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160 [TBL] [Abstract][Full Text] [Related]
18. Effects of Anatolian Propolis and Hypertonic Saline Combination Nasal Spray on Allergic Rhinitis Symptoms: A Prospective, Multicenter Study. Cingi C; Bayar Muluk N; Çukurova İ; Dündar R; Osma U; Bal C; Zirek A; Budak A; Seyed Resuli A; Selimoğlu A; Tanuğur Samancı AE; Karaoğullarından A; Yılmaz B; Arslan B; Sizer B; Cihan C; Koca ÇF; Avcı D; Aydenizöz D; Ünver E; Alaskarov E; Gülmez E; Gündoğan F; Günay G; Çetiner H; Güngör H; Salcan İ; Gündoğan ME; Akbay MÖ; Akdağ M; Kaplama ME; Yaşar M; Koparal M; Kar M; Altıntaş M; Torun MT; Bozan N; Sarı N; Susaman N; Küçük N; Erdoğan O; Gül O; Sancaklı Ö; Kundi P; Budak RO; Karaman S; Taşar S; Demir S; Belli Ş; Yağcı T; Bilici T; Çelik T; Yıldırım YSS; Atayoglu AT; Irkan RK; Zorlu D; Can D Ear Nose Throat J; 2024 Apr; 103(4):NP190-NP198. PubMed ID: 38284348 [No Abstract] [Full Text] [Related]
19. The Comparison of Nasaleze and Mometasone Nasal Spray to Control the Symptoms of Allergic Rhinitis. Mahmoodi NS; Reza Okhovat SA; Reza Abtahi SH; Moslehi A Adv Biomed Res; 2018; 7():27. PubMed ID: 29531925 [TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]